PublicationsIssues Briefs IBThe Pharmaceutical Benefits Scheme (PBS) Access to new and innovative medicines Value of Medicines Value of Australia’s Medicines Industry Investment in clinical trial advances innovation Intellectual property encourages innovation A Guide to Advocacy for Access to Innovative Medicines HTA Review National Medicines Policy Transparency – the need for strong ethical principles Annual Reports Medicines Matter Facts Book Reports and Fact Sheets In this section Protected: The Pharmaceutical Benefits Scheme (PBS)Protected: Access to new and innovative medicinesProtected: Value of MedicinesProtected: Value of Australia’s Medicines IndustryProtected: Investment in clinical trial advances innovationProtected: Intellectual property encourages innovationProtected: A Guide to Advocacy for Access to Innovative MedicinesProtected: HTA ReviewProtected: National Medicines PolicyProtected: Transparency – the need for strong ethical principles This content is password protected. To view it please enter your password below: Password: Previous: Protected: A Guide to Advocacy for Access to Innovative Medicines Next: Protected: National Medicines Policy
